BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cusan M, Mungo G, De Marco Zompit M, Segatto I, Belletti B, Baldassarre G. Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors. Front Endocrinol (Lausanne) 2018;9:393. [PMID: 30065701 DOI: 10.3389/fendo.2018.00393] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Law ZJ, Khoo XH, Lim PT, Goh BH, Ming LC, Lee WL, Goh HP. Extracellular Vesicle-Mediated Chemoresistance in Oral Squamous Cell Carcinoma. Front Mol Biosci 2021;8:629888. [PMID: 33768115 DOI: 10.3389/fmolb.2021.629888] [Reference Citation Analysis]
2 Ghafarkhani M, Avci CB, Rahbarghazi R, Karimi A, Sadeghizadeh M, Zarebkohan A, Bani F. Mild hyperthermia induced by gold nanorods acts as a dual-edge blade in the fate of SH-SY5Y cells via autophagy. Sci Rep 2021;11:23984. [PMID: 34907215 DOI: 10.1038/s41598-021-02697-y] [Reference Citation Analysis]
3 Larouche V, Akirov A, Thain E, Kim RH, Ezzat S. Co-occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes. Endocrinol Diabetes Metab 2019;2:e00092. [PMID: 31592449 DOI: 10.1002/edm2.92] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhu H, Shan Y, Ge K, Lu J, Kong W, Jia C. EIF3B promotes cancer progression in pancreatic cancer. Scand J Gastroenterol 2021;56:281-8. [PMID: 33459066 DOI: 10.1080/00365521.2020.1868566] [Reference Citation Analysis]
5 Lavezzi E, Brunetti A, Smiroldo V, Nappo G, Pedicini V, Vitali E, Trivellin G, Mazziotti G, Lania A. Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management. Front Endocrinol 2022;13:773143. [DOI: 10.3389/fendo.2022.773143] [Reference Citation Analysis]
6 Li J, Xiang C, Wang Y, Zhou Y, Cao S, Ling X, Ye J, Zheng J, Shao L, Zhong H, Han Y. The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors. Ann Transl Med 2021;9:779. [PMID: 34268392 DOI: 10.21037/atm-20-6910] [Reference Citation Analysis]
7 Viotto D, Russo F, Anania I, Segatto I, Rampioni Vinciguerra GL, Dall'Acqua A, Bomben R, Perin T, Cusan M, Schiappacassi M, Gerratana L, D'Andrea S, Citron F, Vit F, Musco L, Mattevi MC, Mungo G, Nicoloso MS, Sonego M, Massarut S, Sorio R, Barzan L, Franchin G, Giorda G, Lucia E, Sulfaro S, Giacomarra V, Polesel J, Toffolutti F, Canzonieri V, Puglisi F, Gattei V, Vecchione A, Belletti B, Baldassarre G. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer. J Pathol 2021;253:234-45. [PMID: 33140857 DOI: 10.1002/path.5584] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chen B, Zhang G, Lai J, Xiao W, Li X, Li C, Mok H, Li K, Wang Y, Cao L, Jia M, Ren C, Wen L, Wei G, Lin J, Li Y, Zhang Y, Chen X, Wu X, Zhang H, Li M, Liu J, Balch CM, Liao N. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours. EBioMedicine 2021;71:103542. [PMID: 34454403 DOI: 10.1016/j.ebiom.2021.103542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang H, Ma X, Liu J, Wan Y, Jiang Y, Xia Y, Cheng W. Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients. Cancer Cell Int 2020;20:306. [PMID: 32684843 DOI: 10.1186/s12935-020-01413-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Xiang P, Sun Y, Fang Z, Yan K, Fan Y. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer. Mamm Genome 2020;31:197-204. [PMID: 32556998 DOI: 10.1007/s00335-020-09842-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Marx SJ, Goltzman D. Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective. J Bone Miner Res 2019;34:22-37. [PMID: 30536424 DOI: 10.1002/jbmr.3650] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Ghaznavi H, Shirvaliloo M, Zarebkohan A, Shams Z, Radnia F, Bahmanpour Z, Sargazi S, Saravani R, Shirvalilou S, Shahraki O, Shahraki S, Nazarlou Z, Sheervalilou R. An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy. Mol Pharmacol 2021;100:119-43. [PMID: 33990406 DOI: 10.1124/molpharm.121.000234] [Reference Citation Analysis]
13 Rampioni Vinciguerra GL, Citron F, Segatto I, Belletti B, Vecchione A, Baldassarre G. p27kip1 at the crossroad between actin and microtubule dynamics. Cell Div 2019;14:2. [PMID: 30976290 DOI: 10.1186/s13008-019-0045-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Guo P, Cai C, Wu X, Fan X, Huang W, Zhou J, Wu Q, Huang Y, Zhao W, Zhang F, Wang Q, Zhang Y, Fang J. An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology. Front Pharmacol 2019;10:857. [PMID: 31447670 DOI: 10.3389/fphar.2019.00857] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
15 Wu C, Wang M, Huang Q, Guo Y, Gong H, Hu C, Zhou L. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients. J Clin Lab Anal 2021;:e24108. [PMID: 34788477 DOI: 10.1002/jcla.24108] [Reference Citation Analysis]
16 Rampioni Vinciguerra GL, Dall'Acqua A, Segatto I, Mattevi MC, Russo F, Favero A, Cirombella R, Mungo G, Viotto D, Karimbayli J, Pesce M, Vecchione A, Belletti B, Baldassarre G. p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer. Cell Death Dis 2021;12:951. [PMID: 34654798 DOI: 10.1038/s41419-021-04241-2] [Reference Citation Analysis]